Weekly CEO Buys Highlight

B. Riley Financial, Advance Auto Parts, Arcus Biosciences, OPKO Health and NGL Energy Partners among stocks bought by insiders

Author's Avatar
Mar 26, 2018
Article's Main Image

According to GuruFocus insider data, these are the largest CEO buys for the past week.

B. Riley Financial CEO bought 221,181 shares

B. Riley Financial Inc. (RILY, Financial) Chairman and CEO Bryant R. Riley bought 221,181 shares on March 16 for $18.25 per share. The stock price has increased by 6.85% since then.

The diversified financial services company, through its subsidiaries, offers investment banking and financial services. The company has a market cap of $519.38 million. On Friday, its shares traded at $19.50 with a price-earnings ratio of 40.62.

The company's net loss for the fourth quarter of 2017 was $6.1 million.

Riley also bought 7,200 shares on March 13 for $18.65 per share. The stock price has risen 4.56% since then.

Advance Auto Parts CEO bought 8,640 shares

Advance Auto Parts Inc. (AAP, Financial) President and CEO Thomas Greco bought 8,640 shares on March 21 for $115.77 per share. The stock price has decreased by 4.26% since then.

The automotive aftermarket parts retailer serves professional installers, do-it-yourself customers and independently-owned operators. The company has a market cap of $8.2 billion. On Friday, its shares were trading around $110.84 with a price-earnings ratio of 17.26.

Its net sales for the fourth quarter of 2017 were $2.04 billion, compared to $2.08 billion in the prior-year period.

Executive Vice President, General Counsel and Corporate Secretary Tammy M. Finley sold 342 shares on March 2 for $116.35 per share. Since then, the stock price has declined 4.74%.

Arcus Biosciences CEO bought 66,666 shares

Terry J. Rosen, CEO of Arcus Biosciences Inc. (RCUS, Financial), bought 66,666 shares on March 19 for $15 per share. The stock price has risen 7.13% since then.

The biotechnology company is focusing on developing innovative cancer immunotherapies. The company has a market cap of $683.79 million. On Friday, its shares were trading aroung $16.07.

On March 19, Arcus Biosciences announced the closing of its initial public offering of 8,000,000 shares at a price of $15 per share.

President Juan C. Jaen bought 66,666 shares on March 19 for $15 per share. Director Kathryn E. Falberg bought 30,000 shares.

OPKO Health CEO bought 175,000 shares

Phillip Frost, chairman, CEO and 10% owner of OPKO Health Inc. (OPK, Financial), bought a total of 175,000 shares over the past week at an average price of $3.37 per share.

The diversified health care company, whose business includes diagnostics and provision of pharmaceutical products, has a market cap of $1.83 billion. Its shares traded around $3.27 on Friday.

Consolidated revenue for the quarter ended Dec. 31 was $193.7 million, compared to $275.5 million in the prior-year period.

Frost bought 61,000 shares on March 15 for $3.32 a share; 40,000 shares on March 19 for $3.51 a share; 75,000 shares on March 20 for $3.32 a share; 30,000 shares on March 21 for $3.38; and 30,000 shares on March 22 for $3.32. The stock price has fallen 1.51% since then.

Senior Vice President and Chief Financial Officer Adam Logal bought 2,065 shares on March 13 for $3.4 per share. The stock price has declined 3.82% since then.

Executive Vice President of Administration Steven D. Rubin bought 6,000 shares on March 7 for $3.25 per share. Since then, the stock price has increased 0.62%.

NGL Energy Partners CEO bought 30,000 shares

NGL Energy Partners LP (NGL, Financial) CEO H. Michael Krimbill bought 30,000 shares on March 16 for $11.22 per share. The stock price has decreased 7.31% since then.

The natural gas company has a market cap of $1.26 billion. Its shares traded around $10.40 on Friday.

Net income for the third quarter of fiscal 2018 was $56.8 million, compared to net income of $1.3 million in the prior-year period.

For the complete list of stocks that were bought by company CEOs, go to CEO Buys.

Disclosure:Â I do not own stock in any of the companies mentioned in the article.